Education
RSM Section Ophthalmology announce one-day meeting on Cancer therapy-related eye toxicities
RSM Section Ophthalmology announce one-day meeting on Cancer therapy-related eye toxicities
The day is shared with the Oncology Section
Date: Friday 14 November 2025
Time: 9:30am to 4:00pm (BST)
Location: Royal Society of Medicine
Early Bird pricing available until 27 September 2025
Register your place now
The section is excited to announce Cancer therapy-related eye toxicities – building new multidisciplinary patient pathways.
Join us for a joint meeting with RSM’s Oncology and Ophthalmology section, uniting professionals in oncology, ophthalmology and optometry to address a growing challenge in modern cancer care.
As Antibody-Drug Conjugates (ADCs) and other innovative cancer therapies transform oncology, an urgent new issue has emerged – ocular toxicities that can impair vision, interrupt treatment, and reduce patient quality of life.
This unique one-day meeting will spotlight:
• Mechanisms behind ADC-related ocular toxicity
• Real-world management strategies
• Imaging and monitoring advancements
• Hands-on workshops and opportunities to co-develop a national multidisciplinary pathway for the NHS
The Royal Society of Medicine,
1 Wimpole Street, London W1G 0AE
+44 (0) 20 7290 2991
To access your Preference Centre click here and update the areas you want to hear about. This can be accessed by logging in clicking on your name in the top right corner and going to the ‘Communication preferences’ page. To unsubscribe click here.
